NCT03400293

Brief Summary

This study is designed to identify the burden associated with HIV and its treatment, and assess their health-related quality of life (HRQoL) by measuring key HRQoL domains, including satisfaction with treatment and care, and internalised stigma (ISAT). The study will also explore data for various important subpopulations such as subjects who are virally suppressed; who we anticipate will be the majority of study subjects. The study design is an observational, cross sectional study employing subjects' own mobile phone devices for data entry.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,184

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 10, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 17, 2018

Completed
1 day until next milestone

Study Start

First participant enrolled

January 18, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 7, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 7, 2018

Completed
Last Updated

March 11, 2019

Status Verified

March 1, 2019

Enrollment Period

6 months

First QC Date

January 10, 2018

Last Update Submit

March 8, 2019

Conditions

Keywords

Human Immunodeficiency virusHealth Related Quality of LifeFunctional Assessment of HIV InfectionMobile app

Outcome Measures

Primary Outcomes (1)

  • Percentage of virally suppressed PLHIV reporting different HRQoL scores

    Evaluation of HRQoL will be conducted using scores achieved by Functional Assessment of HIV Infection (FAHI). QoL assessment will include physical well-being, social well-being, emotional well-being, functional and global well-being, and cognitive functioning

    Up to 1 Week

Secondary Outcomes (4)

  • Percentage of virally suppressed PLHIV reporting different satisfaction with care scores

    Up to 1 Week

  • Percent difference in HRQoL scores among subject subgroups

    Up to 1 Week

  • Percentage of subjects reporting different HRQoL scores and relationship with satisfaction with care

    Up to 1 Week

  • Percentage of subjects reporting diffferent HRQoL and medication adherence

    Up to 1 Week

Study Arms (1)

Subjects living with HIV

Subjects living with HIV will be recruited via digital advertising. These subjects will participate in completing various PRO instruments and targeted questions.

Other: Functional Assessment of HIV InfectionOther: Patient Satisfaction QuestionnaireOther: Symptom Distress ModuleOther: Patient Health QuestionnaireOther: Internalized Stigma of AIDS ToolOther: Medication adherence visual analogue scale

Interventions

Functional Assessment of HIV Infection will be used to assess HRQoL of subjects. This will include 47 items.

Subjects living with HIV

Patient Satisfaction Questionnaire will be used to assess burden and HRQoL in subjects. This will include 18 items.

Subjects living with HIV

Symptom Distress Module will be used to assess burden and HRQoL in subjects. This will include 20 items.

Subjects living with HIV

Patient Health Questionnaire will be used to assess burden and HRQoL in subjects. This will include 2 items.

Subjects living with HIV

Internalized Stigma of AIDS Tool will be used to assess burden and HRQoL in subjects. This will include 10 items.

Subjects living with HIV

Medication adherence visual analogue scale will be used to assess burden and HRQoL in subjects. This will include 1 item.

Subjects living with HIV

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

PLHIV will be recruited advertising in digital media. The study plan is to collect a complete set of data from 3000 PLHIV during a 90-180 day period in the US.

You may qualify if:

  • \>= 21 years old
  • Language:Read and Understand English / Spanish
  • Positive diagnosis of HIV infection by a healthcare provider (self-reported)
  • Possesses a smartphone that has internet access

You may not qualify if:

  • Not Applicable

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

GSK Investigational Site

Arlington, Virginia, 22209, United States

Location

MeSH Terms

Conditions

HIV InfectionsAcquired Immunodeficiency Syndrome

Interventions

Patient Health Questionnaire

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesSlow Virus Diseases

Intervention Hierarchy (Ancestors)

Surveys and QuestionnairesData CollectionEpidemiologic MethodsInvestigative TechniquesPsychological TestsBehavioral Disciplines and ActivitiesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • GSK Clinical Trials

    ViiV Healthcare

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 10, 2018

First Posted

January 17, 2018

Study Start

January 18, 2018

Primary Completion

July 7, 2018

Study Completion

July 7, 2018

Last Updated

March 11, 2019

Record last verified: 2019-03

Locations